Claims Phase III trials at several sites in Texas last year falsified data, broke fundamental rules, and were ‘slow’ to report adverse reactions.
BROADCASTING FOR INDEPENDENCE
BROADCASTING FOR INDEPENDENCE
Claims Phase III trials at several sites in Texas last year falsified data, broke fundamental rules, and were ‘slow’ to report adverse reactions.
